The Effect of BCG Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 13 Feb 2009
At a glance
- Drugs BCG vaccine (Primary)
- Indications Tuberculosis
- Focus Pharmacodynamics
- 13 Feb 2009 Planned number of patients amended from 100 to 180 as reported by ClinicalTrials.gov.
- 13 Feb 2009 Planned end date changed from 1 Dec 2007 to 1 Aug 2009 as reported by ClinicalTrials.gov.
- 13 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.